These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29082658)

  • 21. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
    Robinson JL; Yan N; Caswell C; Xie SX; Suh E; Van Deerlin VM; Gibbons G; Irwin DJ; Grossman M; Lee EB; Lee VM; Miller B; Trojanowski JQ
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):296-304. PubMed ID: 31999351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
    Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy.
    Koizumi R; Akagi A; Riku Y; Miyahara H; Sone J; Tanaka F; Yoshida M; Iwasaki Y
    Parkinsonism Relat Disord; 2024 Oct; 127():106076. PubMed ID: 38494398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
    Rippon GA; Boeve BF; Parisi JE; Dickson DW; Ivnik RI; Jack CR; Hutton M; Baker M; Josephs KA; Knopman DS; Petersen RC
    Neurocase; 2005 Jun; 11(3):204-11. PubMed ID: 16006341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.
    Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V
    Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
    Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate digital quantification of tau pathology in progressive supranuclear palsy.
    Pansuwan T; Quaegebeur A; Kaalund SS; Hidari E; Briggs M; Rowe JB; Rittman T
    Acta Neuropathol Commun; 2023 Nov; 11(1):178. PubMed ID: 37946288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia.
    Chiu WZ; Papma JM; de Koning I; Donker Kaat L; Seelaar H; Reijs AE; Valkema R; Hasan D; Boon AJ; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):910-5. PubMed ID: 22733085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
    Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
    Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
    Delisle MB; Murrell JR; Richardson R; Trofatter JA; Rascol O; Soulages X; Mohr M; Calvas P; Ghetti B
    Acta Neuropathol; 1999 Jul; 98(1):62-77. PubMed ID: 10412802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glial localization of four-repeat tau in atypical progressive supranuclear palsy.
    Motoi Y; Takanashi M; Itaya M; Ikeda K; Mizuno Y; Mori H
    Neuropathology; 2004 Mar; 24(1):60-5. PubMed ID: 15068174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy.
    Allen M; Wang X; Serie DJ; Strickland SL; Burgess JD; Koga S; Younkin CS; Nguyen TT; Malphrus KG; Lincoln SJ; Alamprese M; Zhu K; Chang R; Carrasquillo MM; Kouri N; Murray ME; Reddy JS; Funk C; Price ND; Golde TE; Younkin SG; Asmann YW; Crook JE; Dickson DW; Ertekin-Taner N
    Acta Neuropathol; 2018 Nov; 136(5):709-727. PubMed ID: 30136084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.